- Latest week
- 10 Jul 2026
- Close
- 11.810000
- Fair value
- 12.784000
- Next-week expectancy
- Positive 70.67%
Weekly Close
Trend Line
Fair Value
Activity Lines
Up Week
Down Week
Trend Line
Volume
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Volume Action
Price Action
Market Dynamics
Rate of Change
0
-1.5
Top
Bottom
Raw
Close
Market Strength
30W ROC
Volume Support
Price Action Ribbon
Buy
Flip Up
Flip Down
Market Price Cycle
PC Activity Line
PC Trend Line
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 11.81
- 12-Week Change
- -12.65%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Positive 70.67%
- Signal Weeks
- 0 of 5
- Vs Fair Value
- Below
- Market Dynamics
- 0.00
Over the latest 12 completed weeks ending 2026-07-10, ELOX fell 12.65%, moving from 13.52 to 11.81. The latest weekly close is below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 5 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 70.67% based on similar historical setup states.
Industry Peers
United States equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences Inc | NASDAQ | 10 Jul 2026 | 20.81 | 45.36 | 19.95 | 43.92 | 111.05% |
| CRNX Crinetics Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 42.03 | 83.76 | 41.39 | 83.58 | 98.86% |
| TRAX First Tracks Biotherapeutics | NASDAQ | 10 Jul 2026 | 19.23 | 38.49 | 18.49 | 36.24 | 88.46% |
| TVRD Tvardi Therapeutics, Inc. | NASDAQ | 10 Jul 2026 | 1.95 | 5.69 | 1.95 | 3.28 | 68.21% |
| CBUS Cibus Global LLC | NASDAQ | 10 Jul 2026 | 1.39 | 2.20 | 1.36 | 2.02 | 45.32% |
| AKTX Akari Therapeutics PLC | NASDAQ | 10 Jul 2026 | 9.80 | 15.50 | 9.80 | 13.88 | 41.63% |
| VRAX Virax Biolabs Group Limited Ordinary Shares | NASDAQ | 10 Jul 2026 | 2.95 | 13.19 | 2.84 | 4.08 | 38.31% |
| AARD Aardvark Therapeutics, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 5.59 | 7.92 | 4.66 | 7.60 | 35.96% |
| MSLE Satellos Bioscience Inc. Common Stock | NASDAQ | 10 Jul 2026 | 7.32 | 10.00 | 7.32 | 9.79 | 33.74% |
| TTRX Turn Therapeutics Inc. Common Stock | NASDAQ | 10 Jul 2026 | 7.18 | 11.69 | 7.10 | 9.44 | 31.48% |
| PEPG PepGen Ltd | NASDAQ | 10 Jul 2026 | 1.78 | 2.44 | 1.77 | 2.34 | 31.46% |
| CUE Cue Biopharma | NASDAQ | 10 Jul 2026 | 28.01 | 45.50 | 28.01 | 36.78 | 31.31% |
| LRMR Larimar Therapeutics Inc | NASDAQ | 10 Jul 2026 | 3.29 | 4.32 | 3.21 | 4.28 | 30.09% |
| JSPR Jasper Therapeutics Inc | NASDAQ | 10 Jul 2026 | 0.45 | 0.68 | 0.42 | 0.58 | 29.04% |
| MTVA MetaVia Inc. | NASDAQ | 10 Jul 2026 | 1.41 | 1.80 | 1.41 | 1.78 | 26.24% |
| VSTM Verastem Inc | NASDAQ | 10 Jul 2026 | 4.52 | 5.57 | 4.30 | 5.53 | 22.35% |